The value of monitoring amended reports in cytopathology quality programs: A biennial review
- PMID: 35666141
- DOI: 10.1002/cncy.22607
The value of monitoring amended reports in cytopathology quality programs: A biennial review
Abstract
Background: Quality and safety are the foundation of the practice of cytopathology. Review of key performance indicator (KPI) data can shine a light on laboratory vulnerabilities and potential areas for targeted improvement. The rate and content of amendment reports is a frequently monitored KPI in anatomic pathology, but few have studied its value in cytopathology. The goal of this study was to examine the frequency, classification, and outcome of amendments for a large cytopathology laboratory.
Methods: All amendment reports issued for cases during a 2-year period from July 2019 to June 2021 were included in the study. Amendments were classified into three error type root causes: Specimen Identification Error, General Report Defects, and Diagnostic Error.
Results: A total of 202 amendment reports were issued equating to a rate of 0.275%. A total of 83 (41.1%) were gynecologic cases and 119 (58.9%) were nongynecologic cases. Within the gynecologic cases, 13 (15.7%) cases were due to Specimen Identification Error, 13 (15.7%) cases were due to Diagnostic Error, and 57 (68.7%) cases were due to General Report Defects. Within the nongynecologic cases, 15 (12.6%) cases were due to Specimen Identification Error, 30 (25.2%) cases were due to General Report Defects, and 74 (62.2%) cases were due to Diagnostic Error with 32 of these due to true diagnostic change. Discovery methods included following re-review after additional clinical information was provided, reinterpretation after additional ancillary testing was performed, or conference review. There was no correlation with years in practice.
Conclusions: Studying amendment reports is an underrecognized and valuable quality assurance tool. Amendments can help provide information about types of errors, monitor laboratory processes, and help guide quality improvement endeavors.
Keywords: amendments; cytology; diagnostic error; quality and safety; quality assurance.
© 2022 American Cancer Society.
References
REFERENCES
-
- Heher YK, Chen Y, VanderLaan PA. Measuring and assuring quality performance in cytology: A toolkit. Cancer Cytopathol. 2017;125(S6):502-507.
-
- Cibas ES, Zou KH, Crum CP, Kuo F. Using the rate of positive high-risk HPV test results for ASC-US together with the ASC-US/SIL ratio in evaluating the performance of cytopathologists. Am J Clin Pathol. 2008;129(1):97-101.
-
- Horback K, Sundling KE, Schmidt RJ, Cibas ES. Developing dashboards for performance improvement in cytopathology. J Am Soc Cytopathol. 2021;10(6):535-542.
-
- The Joint Commission Standards on Laboratory Accreditation. Accessed on November 2, 2021. https://www.jointcommission.org/accreditation-and-certification/health-c...
-
- Master Cytopathology Laboratory Accreditation Checklist, College of American Pathologists. Accessed on November 2, 2021. https://elss.cap.org/elss/ShowProperty?nodePath=/UCMCON/Contribution%20F...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources